Marieke van den Beuken
Country: The Netherlands
- Chronic pain in cancer survivors: a growing issueMarieke van den Beuken-van Everdingen
University Hospital, Maastricht, The Netherlands
J Pain Palliat Care Pharmacother 26:385-7. 2012..Pain is reported in 19 to 41% in cancer survivors six months to five years after the disease was cured, and 27 to 35% in survivors of five years or more. The epidemiology, causes and impact of this pain are discussed...
- Prevalence of pain in patients with cancer: a systematic review of the past 40 yearsM H J van den Beuken-van Everdingen
Pain Management and Research Centre, University Hospital Maastricht, Masstricht, The Netherlands
Ann Oncol 18:1437-49. 2007..We investigated the prevalence of pain in cancer patients according to the different disease stages and types of cancer...
- High prevalence of pain in patients with cancer in a large population-based study in The NetherlandsMarieke H J van den Beuken-van Everdingen
University Hospital Maastricht, Pain Management and Research Centre, P O Box 5800, 6202 AZ Maastricht, The Netherlands
Pain 132:312-20. 2007..According to the PMI, analgesic treatment was inadequate in 42% of the patients. Negative predictors of adequate treatment were current curative anti-cancer treatment and low education level...
- Concerns of former breast cancer patients about disease recurrence: a validation and prevalence studyMarieke H J van den Beuken-van Everdingen
Pain Management and Research Center, University Hospital Maastricht, Maastricht, The Netherlands
Psychooncology 17:1137-45. 2008..Second, to measure the prevalence of concerns about disease recurrence in former breast cancer patients and identify potential predictors and third, to establish how fear of recurrence was effecting quality of life...
- Application of adenosine 5'-triphosphate (ATP) infusions in palliative home care: design of a randomized clinical trialSandra Beijer
Department of Epidemiology, Maastricht University, Maastricht, The Netherlands
BMC Public Health 7:4. 2007..To evaluate whether ATP infusions may reduce family caregiver burden and reduce the use of professional health care services, and 3. To test the feasibility of application of ATP infusions in a home care setting...